MGI MouseCyc MP annotations for 7ALPHADEHYDROX-PWY: cholate degradation




Compare annotations to MP categories for 7ALPHADEHYDROX-PWY.
ID Term Akr1c14Slc27a5
MP:0005375adipose tissue phenotypeAkr1c14Slc27a5
MP:0005386behavior/neurological phenotypeAkr1c14Slc27a5
MP:0005378growth/size phenotypeAkr1c14Slc27a5
MP:0005376homeostasis/metabolism phenotypeAkr1c14Slc27a5
MP:0005370liver/biliary system phenotypeAkr1c14Slc27a5


Full set of annotations for 7ALPHADEHYDROX-PWY
IDTermMouse gene AllelesBackgroundColor Key
MP:0004773abnormal bile composition Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Svcolor key
MP:0006319abnormal epididymal fat pad morphology Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Svcolor key
MP:0000607abnormal hepatocyte morphology Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0002118abnormal lipid homeostasis Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0001547abnormal lipid level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0001547abnormal lipid level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Svcolor key
MP:0000609abnormal liver physiology Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0005337abnormal retroperitoneal fat pad morphology Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Svcolor key
MP:0001262decreased body weight Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Svcolor key
MP:0003983decreased cholesterol level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0005179decreased circulating cholesterol level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0002702decreased circulating free fatty acid level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0003458decreased circulating ketone body level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0005668decreased circulating leptin level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Svcolor key
MP:0002644decreased circulating triglyceride level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0003910decreased eating behavior Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Svcolor key
MP:0005282decreased fatty acid level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0005286decreased saturated fatty acid level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0005318decreased triglyceride level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0005285decreased unsaturated fatty acid level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0005292improved glucose tolerance Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Svcolor key
MP:0005533increased body temperature Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Svcolor key
MP:0005559increased circulating glucose level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0002079increased circulating insulin level Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Sv * C57BL/6color key
MP:0005289increased oxygen consumption Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Svcolor key
MP:0005659increased resistance to diet-induced obesity Slc27a5 Slc27a5tm1Asta/Slc27a5tm1Astainvolves: 129/Svcolor key